Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial to Assess the Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam

NCT01887821 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit, Vietnam as lead sponsor.

NCT NCT01887821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01887821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial to Assess the Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
Lead sponsor
Oxford University Clinical Research Unit, Vietnam
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2013
Completion date
June 30, 2015
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasmodium vivax malaria